Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
May 5 (Bloomberg) -- Mark Schoenebaum, head of healthcare research at ISI Group, examines Pfizer’s bid for AstraZeneca as the U.K. government calls for an inquiry into the potential deal on Bloomberg Television’s “Bloomberg Surveillance.”
On Air Now
On The Move
©2014 Bloomberg L.P. All Rights Reserved. Made in NYC